MindMed

@mindmedco

MindMed is a psychedelic medicine biotech company.

Joined September 2019

Tweets

You blocked @mindmedco

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @mindmedco

  1. 11 hours ago

    We are excited to launch a new study evaluating the effects of daytime and evening administration of repeated low doses of LSD. 💤 Learn more:

    Undo
  2. Nov 22
    Undo
  3. Nov 20

    Humans have written a lot about what we see and feel on psychedelics: mischievous spirits, melting faces, even feeling like “a butterfly in a wet suit.” But what do animals experience when they eat psychedelics?

    Undo
  4. Nov 18

    CEO is talking about MindMed worldwide. Most recently, he was at the Jefferies London Healthcare Conference! 🌍 🚀

    Undo
  5. Nov 8

    With young adults facing prolonged COVID isolation, pediatricians and psychiatrists declare a national emergency in youth mental health. Health advocacy groups urge federal policy action.

    Undo
  6. Nov 6

    "In the film Dune, the psychedelic 'spice' enhances various mind expanding functions, but apparently not our prior counterculture search for a loving spiritual awakening." Read more on what Dune says about our societal relationship with psychedelics:

    Undo
  7. Nov 4

    "Like everyone, I went through a lot of intensely heavy stuff in the last year. Somehow this music flowed through me in that time, shining like a constant light in that winter.” Jon Hopkins will release his new album this November.

    Undo
  8. Nov 3

    Despite the fact that around 450 million people globally suffer from mental illnesses, access to mental healthcare is still a challenge and it's crucial to provide treatment. MindMed is helping by using psychedelic medicines and therapies. Learn more:

    Undo
  9. Nov 2

    The U.S. Government recently awarded Johns Hopkins a grant to research how psychedelic therapy can impact tobacco addiction. Learn more about the grant here:

    Undo
  10. Oct 31

    Our CEO Rob Barrow will be speaking at the Web Summit conference in Lisbon this week! Be on the lookout for some fun BTS footage!

    Undo
  11. Oct 29

    CEO Rob Barrow recently spoke about all things MindMed and the next generation of mental health treatment at the Benzinga Healthcare Small Cap Conference. Check out his exclusive interview here:

    Undo
  12. Oct 27

    "Social anxiety disorder is a prevalent and often debilitating psychiatric disorder that can assume a chronic course even when treated." Learn more about MDMA-assisted therapy here:

    Undo
  13. Oct 26

    MindMed is pleased to announce an expansion of its pipeline with the launch of a program to develop R(-)-MDMA for the treatment of social anxiety and functioning in diagnoses that include Autism Spectrum Disorder (ASD).

    Undo
  14. Oct 25

    Tune in now to Dr. Jamileh Jemison, Digital Clinical Director at MindMed, discussing how to "Predict & Prepare for Pitfalls in Decentralized Clinical Trials".

    Undo
  15. Oct 23

    Psilocybin, studied as an anti-depressive treatment, may affect how we perceive music. Learn more about the new academic study here:

    Undo
  16. Oct 21

    ICYMI, MindMed CEO Rob Barrow spoke on "Addressing Mental Health Through Emerging Therapies" at Benzinga's Healthcare Small Cap Conference. Check out the panel here:

    Undo
  17. Oct 19

    MindMed's Project Angie is part of ongoing studies into how psychedelics could help treat physical pain. Learn more about the latest research here:

    Undo
  18. Oct 15

    Researchers are calling the new wave of psychedelic medicines a ‘paradigm shifter’ for psychiatry. Learn more here:

    Undo
  19. Oct 13

    Researchers say “psychedelic-assisted psychotherapy” could be more effective at treating the symptoms of “PTSD, depression, anxiety, addictions, and social disconnection”.

    Undo
  20. Oct 11

    "A 2020 study from Johns Hopkins University showed that two doses of psilocybin produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of the study participants achieving full remission."

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·